Xiaoxuan Xing
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Generic vs. brand-name pramipexole: effectiveness, safety, and cost comparison in a multicenter retrospective cohort study.
Journal: Frontiers in aging neuroscience
Published: May 06, 2026
Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology.
Journal: Frontiers in psychiatry
Published: March 04, 2026
Association of blood-activating commercial Chinese polyherbal preparation with clinical outcomes in older patients with ischemic cardiovascular or cerebrovascular diseases: a real-world cohort study.
Journal: Frontiers in pharmacology
Published: February 27, 2026
Correction: Comparison of treatment patterns, efficacy and safety between generic and branded Atorvastatin users in China: a multicenter, retrospective propensity score‑matched cohort study.
Journal: Lipids in health and disease
Published: October 24, 2025
Therapeutic equivalence and switching between biosimilar and reference insulins: A systematic review and meta-analysis of randomised controlled trials.
Journal: Diabetes, obesity & metabolism
Published: August 17, 2025
Updating the potentially inappropriate medication (PIM)-China criteria for 2024: a Delphi consensus study for improved medication safety in older adults.
Journal: International journal of clinical pharmacy
Published: February 23, 2025
Reply: [Post-marketing safety concerns with Lecanemab: a disproportionality analysis using the FDA adverse event reporting system].
Journal: Alzheimer's research & therapy
Published: February 21, 2025
Comparison of treatment patterns, efficacy and safety between generic and branded atorvastatin users in China: a multicenter, retrospective propensity score-matched cohort study.
Journal: Lipids in health and disease
Published: January 10, 2025
Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records.
Journal: Frontiers in pharmacology
Published: December 02, 2024
Post-marketing safety concerns with lecanemab: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.
Journal: Alzheimer's research & therapy
Published: October 29, 2024
Development of a list of high-risk perioperative medications for the elderly: a Delphi method.
Journal: Expert opinion on drug safety
Published: June 07, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026